Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$12,381,191
+$1,924,925 QoQ
Shares Held
49,202
+2.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.89%
of 13F equity value
Holder Rank
#810
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEARLE & CO. holds $43,484,840 across 9 Drug Manufacturers - General names. ABBV ranks #1 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
49,202 | $12,381,191 | |
| 2 | JNJ |
Johnson & Johnson
|
39,252 | $9,968,830 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,913 | $7,056,320 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
79,700 | $4,592,314 | |
| 5 | LLY |
ELI LILLY & Co
|
3,530 | $4,233,988 | |
| 6 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 7 | PFE |
Pfizer Inc
|
88,705 | $2,136,016 | |
| 8 | SNY |
Sanofi
|
9,500 | $405,270 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,381,191 | 49,202 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $10,456,266 | 48,077 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,916,566 | 47,777 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,062,286 | 47,777 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,831,242 | 47,577 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,968,333 | 47,577 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,418,892 | 47,377 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,158,529 | 46,377 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $8,794,516 | 51,274 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $8,512,628 | 46,747 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,244,382 | 46,747 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,625,269 | 44,447 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $5,988,344 | 44,447 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,083,518 | 44,447 | Shares | Sole | 2023-06-01 | |
| 2022-12-31 | $7,183,079 | 44,447 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,009,252 | 44,775 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $6,857,739 | 44,775 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $7,258,475 | 44,775 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $6,096,114 | 45,023 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $4,824,270 | 44,723 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $5,037,598 | 44,723 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $4,833,213 | 44,661 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,774,711 | 44,561 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,894,338 | 44,461 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $4,365,180 | 44,461 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $3,095,904 | 40,634 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||